Us Bancorp \De\ Ocular Therapeutix, Inc Transaction History
Us Bancorp \De\
- $75.6 Billion
- Q4 2024
A detailed history of Us Bancorp \De\ transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Us Bancorp \De\ holds 317 shares of OCUL stock, worth $2,425. This represents 0.0% of its overall portfolio holdings.
Number of Shares
317
Previous 895
64.58%
Holding current value
$2,425
Previous $7,000
71.43%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding OCUL
# of Institutions
190Shares Held
132MCall Options Held
374KPut Options Held
179K-
Summer Road LLC West Palm Beach, FL13.9MShares$106 Million98.85% of portfolio
-
Deep Track Capital, LP Greenwich, CT12.8MShares$98.2 Million4.83% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$97.6 Million17.98% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$88.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.48MShares$64.9 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $589M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...